Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Vireo Growth Inc. is a cannabis-focused healthcare company that operates in the United States, primarily in states with legalized medical and recreational cannabis markets. The company differentiates itself through its vertically integrated business model, which includes cultivation, processing, and retail distribution of cannabis products, allowing for better control over quality and supply chain.
Vireo generates revenue by selling a range of cannabis products, including oils, edibles, and flower, primarily through its dispensaries and wholesale channels. The company benefits from strong pricing power due to its premium product offerings and established brand reputation in key markets.
Regulatory changes impacting cannabis legalization in key states such as New York and New Jersey
Market share growth in existing states, particularly in Minnesota and Pennsylvania
Product innovation and new product launches in the cannabis sector
Changes in consumer preferences towards cannabis products
Ongoing regulatory changes and potential federal legalization of cannabis could disrupt current business models.
Market saturation in key states may lead to increased competition and pricing pressure.
Emerging cannabis brands with innovative products could capture market share from Vireo.
Large multi-state operators (MSOs) expanding aggressively could threaten Vireo's market position.
High debt-to-equity ratio (1.38) raises concerns about financial leverage and liquidity.
Negative net margins (-25.3%) indicate potential challenges in achieving profitability.
moderate - The cannabis industry is somewhat insulated from economic downturns, but consumer spending patterns can still affect sales.
Higher interest rates could increase borrowing costs for Vireo, impacting its ability to finance expansion and operations, potentially leading to lower valuation multiples.
minimal - Vireo's operations are not heavily reliant on credit markets, but higher debt levels could impact financial flexibility.
growth - Investors looking for exposure to the rapidly expanding cannabis market and potential for high revenue growth.
high - The stock has demonstrated significant price fluctuations, particularly with a 1-year return of -11.4%.